4/A

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: January 24, 2020
Period of Report: December 10, 2019
Accession Number: 0001645470-20-000002

View Document ↗ View on SEC.gov ↗